Molina Healthcare (MOH) Research & Development (2010 - 2018)

Molina Healthcare has disclosed Research & Development across 9 years of filings, most recently posting $120.0 million for Q1 2018.

• In Q1 2018, Research & Development fell 1.64% year-over-year to $120.0 million; the TTM figure through Mar 2018 stood at $490.0 million (up 2.08% YoY), while the FY2017 annual figure was $492.0 million, up 1.44% from the prior year.
• Research & Development came in at $120.0 million for Q1 2018 at Molina Healthcare, down from $123.0 million in the prior quarter.
• In the past five years, Research & Development ranged from a high of $127.0 million in Q1 2016 to a low of $33.0 million in Q2 2015.
• Average Research & Development over 5 years is $85.1 million, with a median of $116.0 million recorded in 2016.
• Year-over-year, Research & Development slipped 15.14% in 2015 and soared 252.78% in 2016.
• Over 5 years, Research & Development stood at $39.2 million in 2014, then surged by 129.77% to $90.0 million in 2015, then jumped by 36.67% to $123.0 million in 2016, then changed by 0.0% to $123.0 million in 2017, then decreased by 2.44% to $120.0 million in 2018.
• Per Business Quant data, the three most recent Research & Development figures were $120.0 million in Q1 2018, $123.0 million in Q4 2017, and $123.0 million in Q3 2017.